Antiplatelets, anticoagulants, and colonoscopic polypectomy

Gastrointest Endosc. 2020 Feb;91(2):257-265. doi: 10.1016/j.gie.2019.09.033. Epub 2019 Oct 1.

Abstract

The management of antiplatelet and anticoagulant (ie, antithrombotic) agents is challenging in the periendoscopic setting. In this state-of-the-art update, we review current best practice recommendations focusing on the risk of immediate and delayed postpolypectomy bleeding in the context of drug discontinuation (ie, temporary interruption) and drug continuation. The data regarding polypectomy technique (cold snare vs conventional thermal-based) and prophylactic placement of hemostatic clips are evaluated to assess whether these endoscopic techniques are beneficial in reducing postpolypectomy bleeding. Finally, clinical takeaways are provided to facilitate safer polypectomy among patients on antiplatelet and anticoagulant agents.

Publication types

  • Review

MeSH terms

  • Anticoagulants / therapeutic use*
  • Aspirin / therapeutic use
  • Colonic Polyps / surgery*
  • Colonoscopy / methods*
  • Deprescriptions
  • Embolism / drug therapy
  • Embolism / prevention & control*
  • Factor Xa Inhibitors / therapeutic use
  • Gastrointestinal Hemorrhage / prevention & control*
  • Heparin / therapeutic use
  • Humans
  • Perioperative Care / methods
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Postoperative Hemorrhage / prevention & control*
  • Purinergic P2Y Receptor Antagonists / therapeutic use
  • Thrombosis / drug therapy
  • Thrombosis / prevention & control*
  • Time Factors

Substances

  • Anticoagulants
  • Factor Xa Inhibitors
  • Platelet Aggregation Inhibitors
  • Purinergic P2Y Receptor Antagonists
  • Heparin
  • Aspirin